Medtronic plc MDT recently shared long-term data from its SPYRAL HTN-ON MED clinical trial. The trial data showed significantly greater reductions in 24-hour ambulatory systolic blood pressure ...

ABT currently has a PEG ratio of 2.81. Another notable valuation metric for MDT is its P/B ratio of 2.46. The P/B ratio pits a stock's market value against its book value, which is defined as ...

I recommend selling Medtronic stock until it achieves significant innovation ... The FCF margin is implied from projected revenue, MDT's current P/FCF, and market capitalization.

Minneapolis, Minnesota-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. With a market ...

Medtronic plc MDT recently shared long-term data from its SPYRAL HTN-ON MED clinical trial. The trial data showed ...

Federated Hermes MDT Mid Cap Growth Fund earns an Above Average ... which tends to hurt stock performance. In recent months, the strategy was more exposed to the Yield factor compared with its ...

Federated Hermes MDT All Cap Core Fund earns a High Process Pillar rating. The leading factor in the rating is the fund's impressive long-term risk-adjusted performance. This can be seen in its ...